Latin America electroceuticals market is expected to grow at a CAGR of around 4% during the forecast period. Latin America registers the significant growth owing to major contribution of the countries including Brazil, Mexico among others. The growing prevalence of ischemic heart disease, age-related and other hearing loss, and epilepsy is creating demand for electroceuticals, thereby, driving the growth of Latin America electroceuticals market. For instance, According to WHO, hearing loss is highest in Sub-Saharan, Latin America, and Caribbean region. The values for the prevalence of age-related and other hearing loss in 2012 was 84.6 million people, which increased up to 96.4 million in 2017. As per the Institute for Health Metrics and Evaluation, in 2017, around 0.4 million fatalities occurred in Latin America due to ischemic heart disease. This noticeable prevalence of diseases is expected to drive the industry growth.
Growing prevalence of spinal cord injuries, age-related and other hearing losses, and ischemic heart disease is anticipated to create demand for electroceuticals in Brazil and CVD, CHD, stroke, heart failure, atrial fibrillation, and other heart diseases are the leading causes of fatalities in Mexico is driving the growth of Latin America electroceuticals market. The market is segmented on the basis of product and end-user. On the basis of product, the market is segmented into cardioverter defibrillators and cardiac pacemaker, deep brain stimulators (DBS), spinal cord stimulators (SCS), vagus nerve stimulators, hearing aids, and cochlear implants, and others such as sacral nerve stimulators, and transcutaneous electrical nerve stimulators. By end-user segment, the market is segmented into hospitals & clinics and homecare and other. Few players operating in the Latin America electroceuticals market include Medtronic PLC, Abbott Laboratories Inc., Boston Scientific Corp., LivaNova PLC, Cochlear, Ltd., Sonova Holding AG, Nevro Corp., ElectroCore LLC, and BioElectronics Corp.
Research Methodology
The market study of the Latin America electroceuticals market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers